Evidence map›Paper›PMID 21883218›Full record

ArticleJournal of neurochemistry2011

Dual neuroprotective pathways of a pro-electrophilic compound via HSF-1-activated heat-shock proteins and Nrf2-activated phase 2 antioxidant response enzymes.

Takumi Satoh, Tayebeh Rezaie, Masaaki Seki, Carmen R Sunico, Takahito Tabuchi, Tomomi Kitagawa, Mika Yanagitai, Mutsumi Senzaki, Chihiro Kosegawa, Hideharu Taira and 4 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of neurochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Circulation research · 2025
    Article
  4. Article
  5. Article
  6. Unlocking Disease-Modifying Treatments for TDP-43-Mediated Neurodegeneration.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Quinones as Neuroprotective Agents.Antioxidants (Basel, Switzerland) · 2023
    Review
  11. Puerarin Alleviates HInternational journal of molecular sciences · 2023
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Induction ofFEBS open bio · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Takumi SatohDepartment of Welfare Engineering, Faculty of Engineering, Iwate University, Morioka, Iwate, Japan. tsatoh@iwate-u.ac.jp
Tayebeh Rezaie
Masaaki Seki
Carmen R Sunico
Takahito Tabuchi
Tomomi Kitagawa
Mika Yanagitai
Mutsumi Senzaki
Chihiro Kosegawa
Hideharu Taira
Scott R McKercher
Jennifer K Hoffman
Gregory P Roth
Stuart A Lipton
Iwate University · JPSanford Burnham Prebys Medical Discovery Institute · US

Funding

PROJECT III - GENETIC APPROACH TO EXCITATORY TRANSMISSIONP01HD029587 · NICHD · SCINTILLON INSTITUTE FOR PHOTOBIOLOGY · PI LIPTON, STUART A · 1992 to 2016
$21.9M
La Jolla Interdisciplinary Neuroscience Center Cores - Vital VP30NS057096 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI LIPTON, STUART A · 2006 to 2010
$12.7M
Project 4: A Developmental Perspective to Nitrosative/Oxidative SusceptibilityP01ES016738 · NIEHS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RIEDL, STEFAN J · 2008 to 2012
$8.5M
RETINAL GANGLION CELLS: ION CHANNEL &TRANSMITTERSR01EY005477 · NEI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI LIPTON, STUART A · 1985 to 2010
$5.0M
CA++ CHANNEL ANTAGONISTS AND AIDS-RELATED NEUROTOXICITYR01EY009024 · NEI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI LIPTON, STUART A · 1991 to 2009
$3.9M
NEI NIH HHS R01 EY005477NEI NIH HHS R01 EY009024NEI NIH HHS R01 EY05477NEI NIH HHS R01 EY09024NICHD NIH HHS P01 HD029587NICHD NIH HHS P01 HD29587NIEHS NIH HHS P01 ES016738NINDS NIH HHS P30 NS057096
6 · The paper itself

Abstract

Activation of the Keap1/nuclear factor erythroid 2-related factor 2 (Nrf2) pathway and consequent induction of phase 2 antioxidant enzymes is known to afford neuroprotection. Here, we present a series of novel electrophilic compounds that protect neurons via this pathway. Natural products, such as carnosic acid (CA), are present in high amounts in the herbs rosemary and sage as ortho-dihydroquinones, and have attracted particular attention because they are converted by oxidative stress to their active form (ortho-quinone species) that stimulate the Keap1/Nrf2 transcriptional pathway. Once activated, this pathway leads to the production of a series of antioxidant phase 2 enzymes. Thus, such dihydroquinones function as redox-activated 'pro-electrophiles'. Here, we explored the concept that related para-dihydroquinones represent even more effective bioactive pro-electrophiles for the induction of phase 2 enzymes without producing toxic side effects. We synthesized several novel para-hydroquinone-type pro-electrophilic compounds (designated D1 and D2) to analyze their protective mechanism. DNA microarray, PCR, and western blot analyses showed that compound D1 induced expression of heat-shock proteins (HSPs), including HSP70, HSP27, and DnaJ, in addition to phase 2 enzymes such as hemeoxygenase-1 (HO-1), NADP(H) quinine-oxidoreductase1, and the Na(+)-independent cystine/glutamate exchanger (xCT). Treatment with D1 resulted in activation of Nrf2 and heat-shock transcription factor-1 (HSF-1) transcriptional elements, thus inducing phase 2 enzymes and HSPs, respectively. In this manner, D1 protected neuronal cells from both oxidative and endoplasmic reticulum (ER)-related stress. Additionally, D1 suppressed induction of 78 kDa glucose-regulated protein (GRP78), an ER chaperone protein, and inhibited hyperoxidation of peroxiredoxin 2 (PRX2), a molecule that is in its reduced state can protect from oxidative stress. These results suggest that D1 is a novel pro-electrophilic compound that activates both the Nrf2 and HSF-1 pathways, and may thus offer protection from oxidative and ER stress.

Indexed as

AntioxidantsCells, CulturedDNA-Binding ProteinsEndoplasmic Reticulum Chaperone BiPHeat Shock Transcription FactorsHumansNeuroprotective AgentsNF-E2-Related Factor 2Oxidative StressQuinonesRetinal Pigment EpitheliumSignal TransductionTranscription FactorsAntioxidantsDNA-Binding ProteinsEndoplasmic Reticulum Chaperone BiPHeat Shock Transcription FactorsHSF1 protein, humanHSPA5 protein, humanNeuroprotective AgentsNFE2L2 protein, humanNF-E2-Related Factor 2QuinonesTranscription Factors

Identifiers

PMID21883218
PMCPMC4580255
OpenAlexW1572853479

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.